MedPath

Acupoint Stimulation and Cranial Endovascular Treatment

Not Applicable
Recruiting
Conditions
Cerebral Aneurysm
Interventions
Device: transcutaneous electrical acupoint stimulation
Registration Number
NCT05413460
Lead Sponsor
Zhihong LU
Brief Summary

In this prospective randomized controlled trial, the subjects will be assigned to group transcutaneous electrical acupoint stimulation (TEAS) and group control (no intervention). The postoperative outcomes including NIHSS (National Institute of Health stroke scale) score, morbidity and mortality will be evaluated during hospital stay and by one year after surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
158
Inclusion Criteria
  1. age ≥18 years
  2. patients scheduled for cranial endovascular treatment
Exclusion Criteria
  1. American Society of Anesthesiologists class Ⅲ or higher
  2. Hunt-Hess class Ⅲ or higher
  3. body mass index (BMI) < 18 kg/㎡ or > 30kg/㎡
  4. large or giant cerebral aneurysms with diameters greater than 15mm and minor cerebral aneurysms with diameters less than 3mm
  5. posterior circulation infarction
  6. recurrence of an cerebral aneurysms after endovascular procedures or surgical clipping
  7. severe abnormal coagulation function, severe liver and kidney function damage, or combined with heart and respiratory system failure
  8. injury or infection of the skin around the acupoint area
  9. participate in other clinical researchers within 3 months
  10. history of neurological or psychiatric diseases
  11. patients with implanted electrophysiological device
  12. use of sedative or analgesics before surgery
  13. patients with difficulty in communication

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
transcutaneous electrical acupoint stimulationtranscutaneous electrical acupoint stimulationElectrodes are placed at acupoints and connected to the stimulator. Electrical stimulation is given during surgery.
Primary Outcome Measures
NameTimeMethod
number of patients with major in-hospital postoperative complicationsfrom end of surgery to discharge from hospital, in an average of 7 days

major complications include myocardial infarction, heart failure, respiratory failure, mechanical ventilation, cerebral infarction, delirium and coma

Secondary Outcome Measures
NameTimeMethod
serum interleukin-6 level at the end of the surgeryat end of the surgery
Score of Mini-mental State Examination at 1 day after surgeryat 24h after the end of surgery

A Mini-Mental State Examination (MMSE) is a set of 30 questions that doctors and other healthcare professionals commonly use to check for cognitive impairment (problems with thinking, communication, understanding and memory). MMSE is with a maximal score of 30. A higher score means better cognitive function.

mortality by 30 days after surgeryfrom end of surgery to 30 days after surgery, in a total of 30 days
mortality by 3 months after surgeryfrom end of surgery to 3 months after surgery, in a total of 3 months
serum tumor necrosis factor-α level at the end of the surgeryat end of the surgery
episodes of hypotension during surgeryfrom start of surgery to end of surgery, in an average of 2 hours

hypotension is defined as mean arterial pressure decreased by more than 20% of the baseline and persisting more than 1 minute

Score of Mini-mental State Examination at 3 days after surgeryat 72h after the end of surgery

A Mini-Mental State Examination (MMSE) is a set of 30 questions that doctors and other healthcare professionals commonly use to check for cognitive impairment (problems with thinking, communication, understanding and memory). MMSE is with a maximal score of 30. A higher score means better cognitive function.

visual analog scale of pain at 1 day after surgeryat 24h after the end of surgery

visual analogue scale is a scale of 10cm, 0 is for no pain, 10 is for pain that can not be tolerated. The participant is asked to mark the scale of their pain

number of patients with major postoperative complications by 3 months after surgeryfrom end of surgery to 3 months after surgery, in a total of 3 months

major complications include myocardial infarction, heart failure, respiratory failure, mechanical ventilation, cerebral infarction, delirium and coma

mortality by 6 months after surgeryfrom end of surgery to 6 months after surgery, in a total of 6 months
visual analog scale of pain at 3 days after surgeryat 72h after the end of surgery

visual analogue scale is a scale of 10cm, 0 is for no pain, 10 is for pain that can not be tolerated. The participant is asked to mark the scale of their pain

Rankin's score at 3 days after surgeryat 72h after the end of surgery

Rankin's score consists of class of 6 levels and is used for evaluation of neurologic function. Higher score means worse outcome.

number of patients with major postoperative complications by 6 months after surgeryfrom end of surgery to 6 months after surgery, in a total of 6 months

major complications include myocardial infarction, heart failure, respiratory failure, mechanical ventilation, cerebral infarction, delirium and coma

duration of postoperative in-hospital stayfrom end of surgery to discharge from hospital, in an average of 7 days
Quality of recovery score at 3 days after surgeryat 72h after the end of surgery

Quality of recovery-40 is a questionnaire consisted of 40 questions about the recovery of the patient. Higher score means better recovery.

Trial Locations

Locations (1)

Xijing hospital, Fourth military medical university

🇨🇳

Xi'an, Shaanxi, China

© Copyright 2025. All Rights Reserved by MedPath